Table 3 Significance of EORTC QLQ-L13 and LCSS scores for overall survival of the lung cancer patients (Univariate and mulitvariate Cox’s regression results)
Variables LC13 | Mean (sd) | N | Crude HR (95 % CI) | Adjusted HRa (95 % CI) |
|---|---|---|---|---|
Dispnoea (ref = 0) | 30.5 | 235 | 1.00 | 1.00 |
>0 | (25.7) | 64 | 0.83 (0.61–1.12) | 1.01 (1.00–1.01) |
Cough (ref = 0) | 39.6 | 220 | 1.00 | 1.00 |
>0 | (32.1) | 79 | 0.93 (0.71–1.22) | 1.00 (1.00–1.01) |
Hemoptysis (ref = 0) | 9.9 | 67 | 1.00 | 1.00 |
>0 | (21.0) | 232 | 1.01 (0.75–1.34) | 1.00 (1.00–1.01) |
Sore Mouth (ref = 0) | 5.8 | 40 | 1.00 | 1.00 |
>0 | (16.3) | 259 | 1.14 (0.79–1.63) | 1.00 (0.99–1.01) |
Dysphagia (ref = 0) | 9.0 | 54 | 1.00 | 1.00 |
>0 | (21.4) | 245 | 0.88 (0.64–1.21) | 1.01 (1.00–1.01) |
Peripheral neuropathy (ref = 0) | 14.0 | 83 | 1.00 | 1.00 |
>0 | (26.3) | 216 | 0.98 (0.75–1.29) | 1.01 (1.00–1.01) |
Hair loss (ref = 0) | 5.9 | 28 | 1.00 | 1.00 |
>0 | (25.7) | 269 | 1.40 (0.91–2.14) | 1.00 (0.99–1.00) |
Chest pain (ref = 0) | 24.5 | 149 | 1.00 | 1.00 |
>0 | (29.7) | 150 | 0.85 (0.67–1.08) | 1.00 (1.00–1.01) |
Pain in arm or shoulder (ref = 0) | 18.1 | 108 | 1.00 | 1.00 |
>0 | (27.7) | 191 | 0.96 (0.74–1.23) | 1.00 (1.00–1.01) |
Other pain sites (ref = 0) | 20.7 | 186 | 1.00 | 1.00 |
>0 | (16.2) | 113 | 1.07 (0.83–1.36) | 1.00 (0.99–1.01) |
LCSS (Lung Cancer Symptom Scale) | ||||
LCSS index score (30.00 ≤ as reference) | 40.5 | 96 | 1.00 | 1.00 |
30.01 > LCSS.I ≤ 45.99 | (20.6) | 99 | 0. 77(0.57–1.05) | 0.82 (0.60–1.21) |
≥46.00 | 101 | 1.16 (0.86–1.55) | 1.06 (0.78–1.42) | |
LCSS symptom score (27.00 ≤ as reference) | 38.1 | 98 | 1.00 | 1.00 |
27.01 > LCSS.S ≤ 43.69 | (21.7) | 96 | 0.74 (0.54–1.00) | 0.76 (0.56–1.04) |
≥43.70 | 102 | 1.20 (0.90–1.62) | 1.12 (0.83–1.52) |